Glaucoma care is evolving, and Glaukos is leading the charge.
At ESCRS 2025, all eyes were on iStent infinite®, marking its European launch and a major step forward in proactive glaucoma management. Designed for patients with moderate to advanced open-angle glaucoma, this next-gen trabecular micro-bypass technology is changing the conversation from managing progression to preventing it.
But innovation isn’t just about new tools. It’s about a new mindset. Hear from Joseph Gilliam and Andrew Geddes as they share how Glaukos is reshaping glaucoma care for the future.
Ready to see where the future of glaucoma treatment is headed? Watch now and learn more at https://www.glaukos.com/
This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all countries.
